Z Zura Bio Ltd: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of Zura Bio Ltd, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €309.3m. The latest transaction was filed on 31 December 2024 (Attribution). Among the most active insiders: Howell Michael. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 31 December 2024
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
◆ Chief Legal Officer · Executives · 1 Oct 2023
500 shares 0Class A Ordinary Shares SEC:0001415889-24-030312:0
▼ Director · Executives · 25 Nov 2024
1,001,633 shares @ US$2.73 13.5% of flow Class A Ordinary Shares SEC:0001415889-24-027847:0
▼ Director · Executives · 11 Sept 2024
3,800,000 shares @ US$2.70 48.1% of flow Class A Ordinary Shares SEC:0001415889-24-023366:0
◆ See Remarks · Executives · 22 Apr 2024
3,195 shares @ US$3.13 50.0% of flow Class A ordinary shares SEC:0001415889-24-023064:0
◆ Director · Executives · 22 Apr 2024
159,744 shares @ US$3.13 33.4% of flow Class A ordinary shares SEC:0001415889-24-023028:0
▼ Director · Executives · 4 Sept 2024
51,728 shares @ US$3.87 4.9% of flow Class A ordinary shares SEC:0001415889-24-023032:0
◆ See Remarks · Executives · 22 Apr 2024
7,987 shares @ US$3.13 23.0% of flow Class A ordinary shares SEC:0001415889-24-023026:0
● See Remarks · Executives · 18 May 2024
9,860 shares @ US$6.05 53.9% of flow Class A ordinary shares SEC:0001415889-24-020979:0
▲ Director · Executives · 17 May 2024
80,000 shares @ US$6.20 100.0% of flow Class A ordinary shares SEC:0001415889-24-014179:0
Ideal exit: 11 Feb 2025 (T+270) ▲ Executive Vice President · Executives · 22 Apr 2024
3,195 shares @ US$3.13 50.0% of flow Class A ordinary shares SEC:0001415889-24-011481:0
Ideal exit: 17 Jan 2025 (T+270) ▲ See Remarks · Executives · 22 Apr 2024
7,987 shares @ US$3.13 23.0% of flow Class A ordinary shares SEC:0001415889-24-011482:0
Ideal exit: 17 Jan 2025 (T+270) ▲ Director · Executives · 22 Apr 2024
159,744 shares @ US$3.13 33.4% of flow Class A ordinary shares SEC:0001415889-24-011480:0
Ideal exit: 17 Jan 2025 (T+270) ▲ Director · Executives · 22 Apr 2024
1,186,901 shares @ US$3.13 95.1% of flow Class A ordinary shares SEC:0001415889-24-011479:0
Ideal exit: 17 Jan 2025 (T+270) ▼ Director · Executives · 12 Dec 2023
2,000,000 shares @ US$4.00 38.4% of flow Class A Ordinary Shares SEC:0001104659-23-126005:0
▲ Director · Executives · 5 Jun 2023
117,647 shares @ US$4.25 33.2% of flow Class A Ordinary Shares SEC:0001104659-23-068206:0
Ideal exit: 1 Mar 2024 (T+270) ◆ Chief Legal Officer · Executives · 18 May 2023
492,381 shares 0Class A Ordinary Shares SEC:0001104659-23-063313:0
◆ See Remarks · Executives · 18 May 2023
114,395 shares 0Class A Ordinary Shares SEC:0001104659-23-063316:0
◆ CMO & Head of R&D · Executives · 18 May 2023
162,060 shares 0Class A Ordinary Shares SEC:0001104659-23-063312:0
550,000 shares @ US$10.4048 100.0% of flow Class A Ordinary Shares, par value $0.0001 per share SEC:0000902664-23-002357:0
● Chief Executive Officer · Executives · 20 Mar 2023
2,337,630 shares Class A ordinary shares SEC:0001104659-23-035745:0